Update on transition to HPV screening consultation

NCSP Manager Helen Colebrook says HPV testing can also be performed less frequently, It may allow the screening interval to be extended from three to five years.  She says HPV testing is also better at identifying women who are at higher risk for developing pre-cancerous changes that could lead to cervical cancer.

‘Internationally, it is well recognised that a change from cytology screening to HPV screening will be needed as HPV immunisation rates continue to increase. In spite of immunisation, it is still important women take part in cervical screening as vaccination does not offer complete protection, and not all women are vaccinated.

‘New Zealand is fortunate in being able to draw on the experiences of other countries that are, or will shortly, be transitioning to HPV primary screening, such as the Netherlands, United Kingdom and Australia. However, it is crucial any decisions made about the programme are tailored to meet the needs of New Zealand women.’ 

Throughout October, the National Screening Unit (NSU) has been consulting on the proposal to transition to HPV primary screening. Twelve public meetings, hui and fono were held around the country. In total, 87 submissions were received from individuals and organisations.

‘The NSU is grateful to those who took the time to attend meetings and give detailed and high-quality feedback,' Helen Colebrook says. 'The NSU is taking the submissions and feedback into account in developing the advice to the Minister on the preferred HPV primary test screening pathway.'

Updates will be provided on the NSU website as the HPV primary screening project progresses.